Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing Spondylitis

Summary

This trial uses a multi-center, randomized, double-blind, placebo, parallel-controlled design, and it is expected that about 105 cases will be enrolled in about 10 sites.

Timeline

Start

2020-12-01

Primary completion

2022-08-02

Completion

2022-08-02

Publications

• Wang J, Bao C, Dai Q, Xu A, Ye Y. Efficacy and safety of jaktinib hydrochloride tablets in active axial spondyloarthritis: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial. RMD Open. 2025 Jan 2;11(1):e004865. doi: 10.1136/rmdopen-2024-004865.

Drugs

Indications